期刊文献+

结核分枝杆菌抗原Rv0173的克隆、表达与纯化 被引量:1

Recombinant Expression,Purification and Identification of Antigen Rv0173 of Mycobacterium tuberculosis(Mtb.)
暂未订购
导出
摘要 目的在大肠杆菌中表达、纯化结核分枝杆菌Rv0173抗原,为研制新型结核病疫苗打下基础。方法将结核杆菌抗原Rv0173的全长cDNA插入到原核表达载体pGEX-4T-1中,构建成Rv0173重组质粒。将重组质粒转入大肠杆菌BL21后用IPTG进行诱导表达,通过SDS-PAGE和Western-blot鉴定重组表达蛋白。结果获得了pGEX4T-Rv0173重组子,Rv0173蛋白在BL21菌中获得表达,表达的蛋白条带大小约45KD,与预期结果相符。结论成功地对结核杆菌免疫保护性抗原Rv0173进行了基因克隆与表达,为进一步研究其在结核病新型疫苗研制中的应用奠定了基础。 Objective To express recombinant antigen Rv0173 of Mycobacterium tuberculosis(Mtb.) for development of novel TB vaccine.Methods The whole gene containing DNA sequence encoding antigen Rv0173 was synthesized and used as a template to amplify the DNA sequence by polymerase chain reaction(PCR) for expressing recombinant Rv0173 protein,containing restriction sites(BamHⅠ、XhoⅠ) on 5' and 3' end respectively.The PCR product was inserted into expression vector pGEX-4T-1 and then the recombinant plasmid was transformed into E.Coli BL21,induced by isopropylthio-β-D-galactoside(IPTG).Results The recombinant 45KD Rv0173 protein was expressed and confirmed by SDS-PAGE and Western-blot.Conclusion The recombinant TB antigen Rv0173 was expressed successfully.
出处 《中国实验诊断学》 2007年第7期914-916,共3页 Chinese Journal of Laboratory Diagnosis
基金 本课题受国家自然科学基金(30471616) 上海市重大科技攻关基金(04DZ19116) 上海市重点科研支撑条件项目(051409012) 上海市青年科技启明星计划项目(QMX01423) 上海市重点基础研究项目(05JC14052)资助
关键词 结核分支杆菌 Rv0173抗原 表达纯化 TB antigen Rv0173 recombinant expression
  • 相关文献

参考文献7

  • 1Collins H L,Kaufmann S H E.Prospects for better tuberculosis vaccines[J].Lancet Infect Disease,2001,1:21.
  • 2Berthet FX,Rasmussen PB,Rosenkrands I,et al.A mycobacterlum tubemdosis operon encoding ESASr'6 and a noval low.Culture filtrate protein[J].Microbiology,1998,114(Ptl1):3159.
  • 3Orme I M.Beyond BCG:The potential for a more effective TB Vccine[J].Mol Med Today,1999,5:487.
  • 4程继忠,皇甫永穆.重组BCG疫苗的研究进展[J].微生物学杂志,1996,16(4):47-50. 被引量:10
  • 5Baldwin SL,Souza C,Roberts A D,et al.Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis[J].Immum,1998,66(6):2951.
  • 6J.Vani,M.S.Shaila,N.R.Chandra b,et al.A combined immuno-informatics and structur-basedmodeling approach for prediction of T cell epitopes of secretory proteins of Mycobacterium tuberculosis[J].Microbes and Infection,2006,8:738.
  • 7吴传勇,娄加陶,蒋廷旺,钱,周晔,陈燕,谷明莉,邓安梅,仲人前.结核杆菌抗原多表位融合蛋白的重组表达与鉴定[J].第二军医大学学报,2006,27(12):1281-1285. 被引量:10

二级参考文献15

  • 1程继忠,邬惠琼,宋瑞琨,皇甫永穆.Effect of In Vivo and in Vitro Treatment with Arsenite on Rat Hepatic Mitochondrial and Microsomal Enzymes[J].Journal of Huazhong University of Science and Technology(Medical Sciences),1996,16(3):155-159. 被引量:2
  • 2Chan ED,Iseman MD.Current medical treatment for tuberculosis[J].BMJ,2002,325:1282-1286.
  • 3Coler RN,Campos-Neto A,Ovendale P,et al.Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis[J].J Immunol,2001,166:6227-6235.
  • 4Smith SM,Klein MR,Malin AS,et al.Human CD(8+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and BCG-vaccinated controls in The Gambia[J].Infect Immun,2000,68:7144-7148.
  • 5娄加陶 吴传勇 蒋廷旺 等.结核杆菌抗原Rv0309的HLA—A*0201限制性CD8^+CTL表位的预测及鉴定[J].中国免疫学杂志,.
  • 6陈军 娄加陶 吴传勇 等.结核杆菌抗原Rv0173的HLA—A*0201限制性CD8^+CTL表位的预测及鉴定[J].中华微生物和免疫学杂志,.
  • 7Geluk A,van Meijgaarden KE,Franken KL,et al.Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+T cells in HLA-transgenic mice and humans[J].J Immunol,2000,165:6463-6471
  • 8Alexander J,Fikes J,Hoffman S,et al.The optimization of helper T lymphocyte (HTL) function in vaccine development[J].Immunol Res,1998,18:79-92.
  • 9Alexander J,Oseroff C,Dahlberg C,et al.A decaepitope polypeptide primes for multiple CD8+ IFN-γ and Th lymphocyte responses:evaluation of multiepitope polypeptides as a mode for vaccine delivery[J].J Immunol,2002,168:6189-6198.
  • 10Lu J,Higashimoto Y,Appella E,et al.Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses[J].J Immunol,2004,172:4575-4582.

共引文献18

同被引文献7

  • 1Ginsberg AM, Spigelman M. Challenges in tuberculosis drug research and development. Nature, 2007, 13: 290-294.
  • 2Chaisson SE. From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nature Medicine, 2007, 13(3): 295-298.
  • 3Cegielshi JP, Chin DP, Espinal MA, et al. The global tuberculosis situation: Progress and broblems in the 20th century, prospects for the 21st century. Infect Dis Clin North Am, 2002, 16: 1-58.
  • 4J萨姆布鲁克,弗里奇,曼尼阿蒂斯T著.分子克隆实验指南.第二版.金冬雁,黎孟枫等译.北京:科学出版社,1995,pp.891-897.
  • 5Kwasi G.Mawuenyega, Christian VF, et al. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Molecular Biology of the cell, 2005, 16: 396-404.
  • 6Abebe F, Holm-Hansen C, Wiker HG, et al. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Journal of Immunology, 2007, 66: 176-191.
  • 7陈曦,张宗德,古淑香,贾红彦,刘忠泉,邢爱英,李自慧,杜博平,黄海荣,马玛.结核分枝杆菌rv3873基因原核表达载体的构建、表达和纯化[J].国际呼吸杂志,2007,27(17):1292-1295. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部